Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation

BACKGROUND: Poor infiltration and limited activation of transferred T cells are fundamental factors impeding the development of adoptive cell immunotherapy in solid tumors. A tumor-penetrating peptide iRGD has been widely used to deliver drugs deep into tumor tissues. CD3-targeting bispecific antibo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Shujuan, Meng, Fanyan, Du, Shiyao, Qian, Hanqing, Ding, Naiqing, Sha, Huizi, Zhu, Mei, Yu, Xiaoxiao, Wang, Lifeng, Liu, Baorui, Wei, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126316/
https://www.ncbi.nlm.nih.gov/pubmed/33986122
http://dx.doi.org/10.1136/jitc-2020-001925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126316/
https://www.ncbi.nlm.nih.gov/pubmed/33986122
http://dx.doi.org/10.1136/jitc-2020-001925

Ejemplares similares